$Cassava Sciences (SAVA.US)$ shares are trading higher after...
$Cassava Sciences(SAVA.US$ shares are trading higher after a review by the Journal of Neuroscience showed there is no evidence of data manipulation in a 2012 company technical paper.Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial.
Cassava Sciences' stock was trading about 42.5% higher at $80.75 per share on Thursday at the time of publication. The stock has a 52-week high of $146.16 and a 52-week low of $6.70.. $Cassava Sciences(SAVA.US$ $Apple(AAPL.US$ $Futu Holdings Ltd(FUTU.US$
Cassava Sciences' stock was trading about 42.5% higher at $80.75 per share on Thursday at the time of publication. The stock has a 52-week high of $146.16 and a 52-week low of $6.70.. $Cassava Sciences(SAVA.US$ $Apple(AAPL.US$ $Futu Holdings Ltd(FUTU.US$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
TheRealJoker : I don't know if your saying that SAVA is a meme stock but SAVA is going to change for the betterment of humans.